View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene Corporation and Ipsen Biopharmaceuticals, Inc.

ASCO GI: Exploring the Modern Management of Pancreatic Cancer: Therapeutic Sequencing, Chemotherapy, and Novel Agents

ASCO GI: Exploring the Modern Management of Pancreatic Cancer: Therapeutic Sequencing, Chemotherapy, and Novel Agents

Thursday, January 23, 2020

Dinner and Registration: 6:00 PM – 7:00 PM
Scientific Session: 7:00 PM – 9:00 PM

The Park Central San Francisco
Dinner and Program: Metropolitan Ballroom 3 - 2nd Floor
50 3rd Street,
San Francisco, CA
(415) 974-6400

Modern Management of Pancreatic Cancer Overview

Recent clinical trials have expanded potential treatment options in pancreatic cancer, a field that has had few options and limited advances for many years. This live symposium will feature expert review and discussion of key clinical trial highlights and ongoing research. With data emerging at a rapid pace, treating your patients with pancreatic cancer will become more complex as new first-line and later line treatment options become available. Navigating these new options and placing emerging data into context for the care of your patients will include challenges in treatment sequencing, applying neoadjuvant and adjuvant therapy options, and incorporating radiotherapy with systemic treatments. In addition to new data guiding the use of chemotherapeutic options, personalized medicine is becoming a reality for patients with pancreatic cancer. Identifying patients with BRCA mutations, mismatch repair deficiency, or NTRK fusions, are already key to guiding treatment with PARP inhibitors, immune checkpoint inhibitors, or NTRK-targeted therapies, respectively. The expert panel will contextualize these recent updates to optimize the care of your patients with pancreatic cancer. In addition, a look to the near future of pancreatic cancer care will cover ongoing clinical trials and relevant preclinical research into the tumor microenvironment and immunological status, as well as targeted therapies in development.

Benefits of Participating in This Live CME Event, Hosted by PER®

  • Hear the latest updates from clinical trials that impact the care of patients with pancreatic cancer now and in the near future.
  • Gain expert perspectives on how new options in pancreatic cancer care can be integrated into the treatment of your patients.
  • Interact with the expert panel to increase your understanding of cutting-edge research in pancreatic cancer care.
  • Learn which ongoing clinical trials may apply to the care of your patients.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Celgene Corporation and Ipsen Biopharmaceuticals, Inc.

Target Audience: HCPs Who Treat Pancreatic Cancer

This educational program is directed toward medical oncologists, radiation oncologists, and surgical oncologists who treat patients with pancreatic cancer. Other attendees who have an interest in the treatment of pancreatic cancer such as nurses, physician assistants, fellows, and residents will also be invited to participate.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess the biological rationale and role of novel formulations of chemotherapeutic agents in expanding treatment options for pancreatic cancer.
  • Evaluate safety and efficacy data reported from recent clinical trials regarding emerging treatment options across lines of care in pancreatic cancer.
  • Integrate emerging data into the treatment paradigm for patients with pancreatic cancer.
  • Formulate a plan of care to monitor and mitigate adverse events associated with pancreatic cancer treatment options.

Program Chair

Shubham Pant
Shubham Pant, MD
Associate Professor, Department of Investigational Cancer Therapeutics
Department of GI Medical Oncology
Associate Director, Early Phase Drug Development
Sheikh Ahmed Center for Pancreatic Cancer Research
University of Texas MD Anderson Cancer Center


2 Ways to Register
  1. Online: Click here.
  2. Phone: Please call +1-(888)-949-0045 or +1-(609)-378-3701.
Physicians' Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Calendar of Events
Filter By